Lv3
380 积分 2023-12-07 加入
The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability
15天前
已完结
Tissue factor pathway inhibitor 2: Current understanding, challenges, and future perspectives
2个月前
已完结
Concizumab improves clot formation in hemophilia A under flow
2个月前
已关闭
Target Joint Status in Patients with Hemophilia a during 18 Consecutive Months of Prophylaxis with a Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life
4个月前
已关闭
Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis
4个月前
已完结
The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors
5个月前
已完结
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis
6个月前
已完结
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension
7个月前
已完结
Pulmonary Arterial Hypertension
7个月前
已完结
皖公网安备34019202002308
